Ankylosing Spondylitis Treatment Market 2020-2026

Global Ankylosing Spondylitis Treatment Market Size, Share & Trends Analysis Report by Drug (Secukinumab, Adalimumab, Golimumab, Infliximab, Etanercept, Certolizumab Pegol, and Other), Forecast Period (2020-2026)
Ankylosing spondylitis treatment market is anticipated to showcase a significant growth rate during the forecast period. The growing FDA approval for different drugs for ankylosing spondylitis is the key factor to drive the growth of the global market. The rising awareness among the population related to this disorder and its treatment is another factor contributing to the growth of the ankylosing spondylitis market across the globe. Although advancement in pain-relieving treatment has made it possible to slow the progression of the ankylosing spondylitis, a complete cure is not possible this fact may act as a restraining factor to the growth of the global market.

The ankylosing spondylitis treatment market is segmented on the basis of the drug into Secukinumab, Adalimumab, Golimumab, Infliximab, Etanercept, Certolizumab Pegol, and Other. Based on drug type, cosentyx is anticipated to exhibit considerable growth in the global ankylosing spondylitis market. In October 2019, Novartis International AG, a pharmaceutical company had received approval from the European Commission (EC) to use Cosentyx (secukinumab) for the treatment of active ankylosing spondylitis.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is anticipated to hold a considerable share in the ankylosing spondylitis market owing to the high investments in the R&D by major market players in the region along with the high incidence of ankylosing spondylitis in the region. However, Asia-Pacific is anticipated to exhibit a modest CAGR due to the rising demand for novel therapies for the treatment of ankylosing spondylitis, due to the presence of a large base of target patient pool in the region.

AbbVie, Inc., Allergen Inc., Eli Lilly and Co., Merck & Co. Inc., Sanofi SA, Pfizer Inc., Bayer AG, Amgen Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline Plc, Bristol-Myers Squibb, Endo Health Solutions, Inc., and so on are the key market operating in the global ankylosing spondylitis treatment market. The major market players are actively adopting growth strategies such as mergers and acquisitions, partnerships, new product launches, investment in R&D activities among others to remain competitive in the global market.

Research Methodology

The market study of the global ankylosing spondylitis treatment market is incorporated by extensive primary and secondary research conducted. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity in the reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Ankylosing Spondylitis Treatment Market Research and Analysis by Drug

The Report Covers

• Comprehensive research methodology of the global ankylosing spondylitis treatment market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global ankylosing spondylitis treatment market.
• Insights about market determinants which are stimulating the global ankylosing spondylitis treatment market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.